Disclaimer

Clicking the images or links will redirect you to a website hosted by BenchSci that provides third-party scientific content. Neither the content nor the BenchSci technology and processes for selection have been evaluated by us; we are providing them as-is and without warranty of any kind, including for use or application of the Thermo Fisher Scientific products presented.

  • Primary Antibodies ›
  • p53 Antibodies

OriGene

p53 Monoclonal Antibody (OTI2E4), TrueMAB™

View all (364) p53 antibodies

{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}

{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}

{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}

Datasheet
Protocols
Questions & Answers
Datasheet
Protocols
Questions & Answers

Cite p53 Monoclonal Antibody (OTI2E4), TrueMAB™

  • Antibody Testing Data (6)
p53 Antibody in Immunocytochemistry (ICC/IF)
Group 53 Created with Sketch.
p53 Antibody in Immunocytochemistry (ICC/IF)
Group 53 Created with Sketch.

FIGURE: 1 / 6

{{ $ctrl.currentElement.advancedVerification.fullName }}
{{ $ctrl.currentElement.advancedVerification.text }}

p53 Antibody (TA502783) in ICC/IF

Anti-TP53 mouse monoclonal antibody (TA502783) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY TP53(RC200003). {{ $ctrl.currentElement.advancedVerification.fullName }} validation info. View more
Published figure supplied by benchsci-logo
PMID: {{$ctrl.currentElement.benchSciPubmedId}}
View Product

{{$ctrl.videoDesc}}

{{$ctrl.videoLongDesc}}

p53 Antibody in Immunocytochemistry (ICC/IF)
p53 Antibody in Western Blot (WB)
p53 Antibody in Western Blot (WB)
p53 Antibody in Flow Cytometry (Flow)
p53 Antibody in Flow Cytometry (Flow)
p53 Antibody in Flow Cytometry (Flow)
p53 Monoclonal Antibody (OTI2E4), TrueMAB™

Product Details

TA502783

Applications
Tested Dilution
Publications

Western Blot (WB)

1:500-1:2,000
-

Immunocytochemistry (ICC/IF)

1:100
-

Flow Cytometry (Flow)

1:100
-
Product Specifications

Species Reactivity

Human, Mouse

Host/Isotype

Mouse / IgG1

Class

Monoclonal

Type

Antibody

Clone

OTI2E4

Immunogen

Full length human recombinant protein of human TP53 produced in HEK293T cell.
View immunogen

Conjugate

Unconjugated Unconjugated Unconjugated

Form

Liquid

Concentration

1 mg/mL

Purification

Affinity chromatography

Storage buffer

PBS with 1% BSA, 50% glycerol

Contains

0.02% sodium azide

Storage conditions

-20°C, Avoid Freeze/Thaw Cycles

Shipping conditions

Ambient (domestic); Wet ice (international)

Target Information

The tumor suppressor protein, p53, is a sequence specific transcription factor that is activated by cellular stress. p53 mediates cell cycle arrest or apoptosis in response to DNA damage or starvation for pyrimidine nucleotides. p53 is up-regulated in response to stress signals and stimulated to activate transcription of specific genes, resulting in expression of p21waf1 and other proteins involved in G1 or G2/M arrest. The structure of p53 comprises an N-terminal transactivation domain, a central DNA-binding domain, an oligomerisation domain, and a C-terminal regulatory domain. There are various phosphorylation sites on p53, of which the phosphorylation at Ser15 is important for p53 activation and stabilization. p53 has been characterized to play a role in blocking the proliferative action of damaged cells and act as an anticancer agent. Phosphorylation of Ser392 in p53 has been shown to associate with the formation of human tumors. In addition, p53 has also been linked to the effects of aging and oxidative stress and an increase in p53 has been linked to deficits in LTP (Long Term Potentiation) in learning and memory. p53 is found in very low levels in normal cells, however, in a variety of transformed cell lines, it is expressed in high amounts, and believed to contribute to transformation and malignancy. Mutants of p53 that frequently occur in a number of different human cancers fail to bind the consensus DNA binding site, and cause the loss of tumor suppressor activity. Alterations of the TP53 gene occur not only as somatic mutations in human malignancies, but also as germline mutations in some cancer-prone families such as Li-Fraumeni syndrome.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.

References (0)

Have you cited this product in a publication?
Let us know so we can reference it here.
Cite this product

Bioinformatics

Protein Aliases: Antigen NY-CO-13; Cellular tumor antigen p53; Cys 51 Stop; FLJ92943; HGNC11998; mutant p53; mutant tumor protein 53; OTTMUSP00000006194; p53 cellular tumor antigen; p53 tumor suppressor; Phosphoprotein p53; transformation-related protein 53; tumor protein 53; Tumor suppressor p53; tumor supressor p53; Tumour Protein p53

View more View less

Gene Aliases: bbl; BCC7; bfy; bhy; LFS1; p44; P53; TP53; TRP53

View more View less

UniProt ID: (Human) P04637, (Mouse) P02340

View more View less

Entrez Gene ID: (Human) 7157, (Mouse) 22059

View more View less

Function(s)
RNA polymerase II transcription factor activity, sequence-specific DNA binding core promoter sequence-specific DNA binding RNA polymerase II transcription factor binding transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding protease binding p53 binding DNA binding chromatin binding damaged DNA binding double-stranded DNA binding transcription factor activity, sequence-specific DNA binding copper ion binding protein binding ATP binding transcription factor binding zinc ion binding enzyme binding protein kinase binding protein phosphatase binding receptor tyrosine kinase binding ubiquitin protein ligase binding histone acetyltransferase binding identical protein binding sequence-specific DNA binding protein self-association transcription regulatory region DNA binding protein heterodimerization activity protein N-terminus binding chaperone binding protein phosphatase 2A binding RNA polymerase II regulatory region sequence-specific DNA binding RNA polymerase II core promoter sequence-specific DNA binding transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding transcription cofactor binding protein C-terminus binding histone deacetylase regulator activity metal ion binding MDM2/MDM4 family protein binding
Process(es)
protein import into nucleus, translocation negative regulation of transcription from RNA polymerase II promoter DNA strand renaturation in utero embryonic development somitogenesis release of cytochrome c from mitochondria T cell proliferation involved in immune response B cell lineage commitment T cell lineage commitment positive regulation of leukocyte migration response to ischemia nucleotide-excision repair double-strand break repair transcription, DNA-templated regulation of transcription, DNA-templated regulation of transcription from RNA polymerase II promoter transcription from RNA polymerase II promoter protein complex assembly apoptotic process cellular response to DNA damage stimulus DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator response to oxidative stress ER overload response cell cycle cell cycle arrest transforming growth factor beta receptor signaling pathway multicellular organism development gastrulation negative regulation of neuroblast proliferation central nervous system development cell aging protein localization negative regulation of DNA replication negative regulation of cell proliferation determination of adult lifespan rRNA transcription response to UV response to salt stress embryo development ending in birth or egg hatching response to X-ray response to gamma radiation positive regulation of cardiac muscle cell apoptotic process programmed cell death viral process cerebellum development negative regulation of cell growth DNA damage response, signal transduction by p53 class mediator negative regulation of transforming growth factor beta receptor signaling pathway chromosome breakage positive regulation of histone deacetylation chromatin assembly mitotic G1 DNA damage checkpoint positive regulation of protein oligomerization T cell differentiation in thymus regulation of tissue remodeling cellular protein localization cellular response to UV multicellular organism growth positive regulation of mitochondrial membrane permeability regulation of cell proliferation cellular response to glucose starvation response to drug intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator regulation of apoptotic process positive regulation of apoptotic process negative regulation of apoptotic process entrainment of circadian clock by photoperiod mitochondrial DNA repair regulation of neuron apoptotic process positive regulation of neuron apoptotic process positive regulation of cell cycle negative regulation of proteolysis negative regulation of transcription, DNA-templated positive regulation of transcription, DNA-templated negative regulation of mitotic cell cycle positive regulation of transcription from RNA polymerase II promoter negative regulation of fibroblast proliferation rhythmic process circadian behavior embryonic organ development negative regulation of smooth muscle cell proliferation positive regulation of peptidyl-tyrosine phosphorylation regulation of catalytic activity protein tetramerization chromosome organization neuron apoptotic process regulation of intracellular pH regulation of cell cycle positive regulation of transcription from RNA polymerase II promoter in response to hypoxia intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress regulation of thymocyte apoptotic process positive regulation of thymocyte apoptotic process necroptotic process positive regulation of cell cycle arrest cellular response to ionizing radiation cellular response to UV-C mitotic cell cycle arrest intrinsic apoptotic signaling pathway by p53 class mediator regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter positive regulation of release of cytochrome c from mitochondria positive regulation of cell aging replicative senescence oxidative stress-induced premature senescence oligodendrocyte apoptotic process positive regulation of execution phase of apoptosis negative regulation of macromitophagy regulation of mitochondrial membrane permeability involved in apoptotic process regulation of intrinsic apoptotic signaling pathway by p53 class mediator regulation of hydrogen peroxide-induced cell death negative regulation of glucose catabolic process to lactate via pyruvate intrinsic apoptotic signaling pathway in response to hypoxia positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress regulation of fibroblast apoptotic process negative regulation of DNA biosynthetic process negative regulation of reactive oxygen species metabolic process positive regulation of reactive oxygen species metabolic process regulation of cellular senescence positive regulation of intrinsic apoptotic signaling pathway base-excision repair Ras protein signal transduction cell proliferation positive regulation of gene expression protein sumoylation cell differentiation cellular response to drug proteasome-mediated ubiquitin-dependent protein catabolic process response to antibiotic positive regulation of protein export from nucleus regulation of mitochondrial membrane permeability negative regulation of helicase activity negative regulation of telomerase activity cellular response to hypoxia intrinsic apoptotic signaling pathway positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway regulation of signal transduction by p53 class mediator regulation of cell cycle G2/M phase transition
It has to be done as per old AB suggested Products section.
guarantee_icon

Performance Guarantee

If an Invitrogen™ antibody doesn't perform as described on our website or datasheet,we'll replace the product at no cost to you, or provide you with a credit for a future purchase.*

Learn more
help_icon

We're here to help

Get expert recommendations for common problems or connect directly with an on staff expert for technical assistance related to applications, equipment and general product use.

Contact tech support

Your items have has been added!


Host server : magellan-search-649bfd9c6b-jlsz7:80/100.66.128.142:80.
git-commit: 6001d82975f0049f9efc09ec70b1b2d89229eeb3
git-url: https://github.com/thermofisher/magellan-search
git-branch: release/2.36.2-2025.09.39-1.0